{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-089781","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.586678+00:00","generated_at":"2026-06-11T19:57:31.323101+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Applied DNA Q3 revenue down to $2.9M; net loss widens to $3.1M; acquires Spindle Biotech","bullets":["Revenue $2.9M vs $4.3M YoY; decline driven by COVID-19 testing drop and CUNY contract wind-down.","Net loss $3.1M vs $1.1M YoY; operating loss flat at $2.9M; gross margin improved to 44%.","Cash $10.8M at June 30, down from $12.3M at March 31; Adjusted EBITDA -$2.1M.","Acquired Spindle Biotech post-quarter; launched Linea IVT platform for mRNA production.","NYSDOH PGx diagnostic approval pending; added new CertainT customers for supply chain traceability."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-089781","json":"https://secwatch.observer/filing/0001104659-23-089781.json","markdown":"https://secwatch.observer/filing/0001104659-23-089781.md","text":"https://secwatch.observer/filing/0001104659-23-089781.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465923089781/0001104659-23-089781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465923089781/tm2323420d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T19:57:31.323101+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"177eeb1fae1b95f3dfb077ef1a6eb883e7825c9f","claim":"BNB PLUS CORP. reported third quarter of fiscal 2023 ended June 30, 2023 results: revenue approximately $2.9 million, net income $3.1 million.","evidence_excerpt":"potential for cotton taggant orders and the initiation of large supply chain customers.” Summary Third Quarter Fiscal 2023 Financial Results: · Total revenues were approximately $2.9 million for the three-month period June 30, 2023, compared to $4.3 million for the same period in the prior fiscal year. The decrease in revenue of approximately $1.4 million was due to","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/744452/000110465923089781/0001104659-23-089781-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter of fiscal 2023 ended June 30, 2023"},{"label":"Revenue","value":"approximately $2.9 million"},{"label":"Net income","value":"$3.1 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}